Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Association of Sjögren's Syndrome with Meibomian Gland Dysfunction
NCT03434106Unknown
- Sponsor
- Lanzhou University
- Start
- Feb 2018
- Primary completion
- May 2018
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of carbomer vaginal gel and Tears Naturale Forte in Sjögren's syndrome and meibomian gland dysfunction (MGD) (4 arms), sponsored by Lanzhou University. Primary endpoints: Ocular Surface Disease Index at 3 months, Meibomian gland function at 3 months and 3 more. Status: unknown.
02
Drugs
carbomer vaginal gelTears Naturale Forte
03
Conditions
Sjögren's syndromemeibomian gland dysfunction (MGD)
Beyond the preview
Go deeper on NCT03434106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434106.